Colonic Stents Market Size, Share, Growth Analysis 2032
Colonic Stents Market Size and Forecast (2025 - 2032), By Product Type (Self-expanding Metal Stents, Plastic Stents), By Disease Indication (Colorectal Cancer, Benign Colonic Strictures), By End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics), and Geography.
Market Overview:
The global Colonic Stents Market is expected to reach a high CAGR of 5.2% over the Forecast Period 2025-2032. The market will increase from USD XX billion in 2024 to USD YY billion in 2032. North America now dominates the market, accounting for the vast majority of global sales. Rising colorectal cancer rates, growing usage of minimally invasive procedures, and technological advancements in stent design are among the key metrics.
The market for colonic stents is quickly expanding because of the rising prevalence of colorectal illnesses, particularly colorectal cancer. Technological advances in stent materials and designs are improving patient outcomes and increasing the scope of these devices. The shift to minimally invasive procedures, paired with an ageing population, is fuelling market growth.
Market Dynamics:
Market trend: shift towards biodegradable and drug-eluting colonic stents for improved patient outcomes
The colonic stent market is shifting significantly towards biodegradable and drug-eluting stents. These advanced stents have several advantages over traditional metal stents, including a lower risk of complications and improved long-term outcomes. Biodegradable stents disintegrate in the body over time, eliminating the need for removal procedures and decreasing the risk of stent-related complications. In contrast, drug-eluting stents release medicines locally to prevent restenosis and promote healing. This trend is being driven by an increasing emphasis on patient-centred care and the need for more effective long-term colon disease management. Manufacturers are investing much in research and development to improve the design and functionality of these new stents, providing more options for healthcare providers and patients. As clinical proof for the efficacy of biodegradable and drug-eluting stents grows, so will their utilisation, altering the colonic stents market landscape.
Market Driver: Rising prevalence of colorectal cancer and increasing adoption of minimally invasive procedures
The increased incidence of colorectal cancer is a significant driver of the colonic stent market. According to the World Health Organisation, colorectal cancer is the world's third most common disease, with over 1.9 million new cases projected in 2020. This high incidence rate highlights the importance of appropriate therapeutic options, such as palliative colonic stents and bridge-to-surgery procedures. Furthermore, the growing popularity of minimally invasive procedures is fuelling market growth. Colonic stenting is a less invasive alternative to traditional surgical treatments, which leads to shorter hospital stays, fewer complications, and an improved quality of life for patients. Research in the Journal of Gastrointestinal Surgery discovered that employing colonic stents as a bridge to surgery lowered overall complication rates by 12% when compared to emergency surgery for malignant colonic obstruction. Furthermore, the cost-effectiveness of stenting therapies appeals to both healthcare providers and payers, with savings of up to 30% compared to typical surgical methods.
Market Restraint: Complications associated with colonic stents and limited reimbursement policies
Despite the rising popularity of colonic stents, various issues with their utilisation pose a danger to market growth. Potential consequences after therapy include stent migration, perforation, and re-obstruction. A meta-analysis in the World Journal of Gastroenterology discovered a technical failure rate of 5.8% and a clinical failure rate of 12.7% for colonic surgical procedures. These outcomes can lead to extra interventions and increased healthcare costs, discouraging some healthcare practitioners from recommending screening as a first-line therapy choice.
Segment Overview:
Self-expanding metal stents (SEMS) dominate the product type segment, driven by their superior performance and durability.
The SEMS segment dominates the colonic stent market. SEMS offer several advantages over plastic stents, including larger lumen sizes, longer patency periods, and lower migration rates. These advantages have resulted in widespread use in palliative care and bridge-to-surgery applications.
Recent developments in SEMS technology have increased its market dominance. For example, Boston Scientific's WallFlex Colonic Stent device, which features a unique flared end design, has produced improved migration rates. A multicenter study published in the journal Gastrointestinal Endoscopy discovered that the WallFlex device had a technical success rate of 98% and a clinical success rate of 87%.
Colorectal cancer is driving strong growth in the SEMS industry. The American Cancer Society estimates that 20–25% of colorectal cancer patients have malignant major intestinal blockages. SEMS has emerged as the primary treatment option for these obstructions, especially in patients who are poor surgical candidates or require neoadjuvant therapy before definitive surgery.
Regional Outlook:
North America leads the global colonic stent market, driven by advanced healthcare infrastructure and a high prevalence of colorectal diseases.
North America now dominates the global colonic stent market, accounting for the great bulk of sales. This dominance is attributable to a number of factors, including the region's outstanding healthcare infrastructure, a high prevalence of colorectal illnesses, and favourable payment policies.
The United States, in particular, has a substantial impact on the region's market leadership. According to the American Cancer Society, colorectal cancer is the third most common disease in both men and women in the United States, with a projected 104,270 new cases in 2021. This high incidence rate has increased the need for effective therapeutic options, such as colonic stents.
Recent developments in the North American market have boosted its standing. For example, the US Food and Drug Administration's clearance of new colonic stent designs and materials has provided patients with more treatment options. In 2020, the FDA designated a novel drug-eluting colonic stent as a breakthrough device, demonstrating the region's dedication to innovation in this field.
Key statistics demonstrate North America's commercial dominance. According to National Institutes of Health data, the use of colonic stents as a bridge to surgery increased by 30% in the United States between 2015 and 2020. Furthermore, studies published in the Journal of the American College of Surgeons found that colonic stenting reduced the need for emergency surgery by 35% in patients with malignant colorectal obstruction.
The Canadian market has also contributed to the region's growth, with the Canadian Agency for Drugs and Technologies in Health reporting a 25% increase in colonic stent procedures in the last five years.
Competitive Intelligence:
The colonic stents industry is typified by severe competition among major players, with a focus on product innovation and strategic collaborations. Leading firms are investing much in R&D to develop new technologies and expand their product offerings.
Boston Scientific Corporation has a substantial market share because of its WallFlex Colonic Stent device. In its 2023 financial report, the company claimed that its endoscopy segment, which includes colonic stents, increased by 15% year on year. Medtronic plc follows closely, with its Evolution Colonic Controlled Release Stent gaining acceptance in key markets.
Cook Medical has improved its position by completing strategic acquisitions and expanding its distribution network into new markets. According to industry statistics, the company's colonic stent sales climbed YY% in 2023.
Olympus Corporation has tried to develop nitinol-based stents with greater flexibility and radial force. The company's endoscopy division, which provides colonic stents, increased sales by 7% in the most recent fiscal year.
Merit Medical Systems, Inc. has grown its market share with the EndoMAXX fully covered self-expanding metal stent, particularly in Europe. The company reported a 20% increase in gastrointestinal product sales in 2023.
Recent mergers and acquisitions, such as a leading medical device manufacturer acquiring AngioDynamics' Soft Tissue and Vascular Access operations in 2022, have altered the competitive landscape. This consolidation trend is likely to continue, potentially resulting in increased market concentration.
Looking ahead, key competitors are focused on expanding their presence in emerging markets, particularly Asia-Pacific and Latin America, where colorectal cancer rates are rapidly increasing. Furthermore, collaborations between healthcare providers and research institutes to conduct clinical trials and collect real-world evidence are becoming increasingly important in maintaining a competitive advantage.
Analyst Opinion:
The market for colonic stents is predicted to grow rapidly in the next few years, thanks to technological developments and growing awareness of the advantages of less invasive procedures. The move towards personalised treatment is likely to promote innovation in stent design, with an emphasis on tailoring devices to specific patient anatomy and disease characteristics.
The use of artificial intelligence and machine learning in stent insertion techniques is an emerging topic to watch. These technologies have the potential to improve stent selection accuracy and patient outcomes. Early studies have provided promising results, with AI-assisted stent placement reducing treatment times by up to 30% and raising technical success rates.
Major Players:
-
Boston Scientific Corporation
-
Cook Medical
-
Olympus Corporation
-
ELLA-CS, s.r.o.
-
Merit Medical Systems, Inc.
-
M.I. TECH
-
Taewoong Medical Co., Ltd.
-
LINOS Medizintechnik GmbH
-
Medtronic plc
-
Becton, Dickinson, and Company
Key Developments:
-
In January 2024, Boston Scientific Corporation received FDA approval for its next-generation colonic stent, which contains a new coating technology to reduce migration risks.
-
Cook Medical stated in November 2023 that it would collaborate with a leading AI startup to develop an AI-assisted stent insertion device for severe colorectal obstructions.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking—Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)
5. COMPANY PROFILES
5.1. Boston Scientific Corporation
5.2. Cook Medical
5.3. Olympus Corporation
5.4. ELLA-CS, s.r.o.
5. Merit Medical Systems, Inc.
5.6. M.I.TECH
5.7. Taewoong Medical Co., Ltd.
5.8. LINOS Medizintechnik GmbH
5.9. Medtronic plc
5.10. Becton, Dickinson, and Company (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards biodegradable and drug-eluting colonic stents
6.1.2. Integration of AI and machine learning in stent placement procedures
6.1.3. Personalised stent designs for improved patient outcomes
6.2. Market Drivers
6.2.1. Rising prevalence of colorectal cancer and increasing adoption of minimally invasive procedures
6.2.2. Technological advancements in stent materials and designs
6.2.3. Growing geriatric population susceptible to colorectal diseases
6.3. Market Restraints
6.3.1. Complications associated with colonic stents and limited reimbursement policies
6.3.2. High cost of advanced stent technologies
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%) -- 2025-2032)
7.1. Self-expanding Metal Stents (SEMS)
7.1.1. Uncovered SEMS
7.1.2. Covered SEMS
7.2. Plastic Stents
7.2.1. Biodegradable Stents
7.2.2. Non-biodegradable Stents
8. BY DISEASE INDICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%) -- 2025-2032)
8.1. Colorectal Cancer
8.1.1. Palliative Care
8.1.2. Bridge to Surgery
8.2. Benign Colonic Strictures
8.2.1. Post-surgical Anastomotic Strictures
8.2.2. Inflammatory Bowel Disease-related Strictures
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%) -- 2025-2032)
9.1. Hospitals
9.1.1. Public Hospitals
9.1.2. Private Hospitals
9.2. Ambulatory Surgical Centres
9.3. Speciality Clinics
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%) -- 2025-2032)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%, YOY GROWTH (%) -- 2025-2032.
By Product Type:
-
Self-expanding Metal Stents (SEMS)
-
Plastic Stents
By Disease Indication:
-
Colorectal Cancer
-
Benign colonic restrictions
By End User:
-
Hospitals
-
Ambulatory Surgical Centres
-
Speciality Clinics
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511